Longeveron appoints Lisa Locklear as CFO effective July 31, 2023

Longeveron Inc.

Lisa Locklear appointed EVP and CFO; base salary $400k, target bonus 45% of salary.
Received 40,000 time-vesting RSUs under 2021 Incentive Award Plan.
Interim CFO James Clavijo steps down July 31 but remains available for transition.
Locklear most recently SVP & CFO of Avanir Pharmaceuticals (Sept 2018-Dec 2022).
Severance: 3 months base salary per year of service if terminated without cause or resigns for good reason.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed (interim)

James Clavijo

Interim Chief Financial Officer

LGVN · Longeveron Inc.

Effective: 2023-07-31
Successor: Lisa Locklear
Filed: July 20, 2023, 7:59 PM ET

James Clavijo, who has been serving as interim CFO on a consulting basis while the Company searched for a permanent CFO, will step down from that interim position as of July 31, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James Clavijo departed as Interim Chief Financial Officer at Longeveron Inc..

Action: step down
Role: Interim Chief Financial Officer

Exact text from the filing

James Clavijo, who has been serving as interim CFO on a consulting basis while the Company searched for a permanent CFO, will step down from that interim position as of July 31, 2023

View on SEC.gov

Longeveron Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-058324

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.